Analysis on Reasons of Unreasonable Medical Orders in 33 Cases of Neuronutritional Auxiliary Medication*1

QIAO Chen, MIAO Xu, WU Lin, CHEN Xia

PDF(1801 KB)
KANGGANRAN YAOXUE
KANGGANRAN YAOXUE ›› 2019, Vol. 16 ›› Issue (8) : 1324-1327. DOI: 10.13493/j.issn.1672-7878.2019.08-008

Analysis on Reasons of Unreasonable Medical Orders in 33 Cases of Neuronutritional Auxiliary Medication*1

  • QIAO Chen*2, MIAO Xu, WU Lin, CHEN Xia
Author information +
History +

Abstract

Objective: To analyze the reasons of unreasonable medical orders for neuronutritional auxiliary medication in hospitalized patients, and to provide a reference for improving the mechanism of auxiliary drug use and rational use of neurotrophic drugs. Methods: From May 2018 to May 2019, 240 orders of neuronutrition-assisted drugs were selected and the reasons for unreasonable drug use were analyzed. Results: Among the 240 medical orders, 29 cases of unreasonable medical orders accounted for 12.08%, and the other 4 cases accounted for 1.67%. The reasons are mainly unsuitable indications, unsuitable selection of drugs, unsuitable route of drug administration, unsuitable usage and dosage, unsuitable selection of solvent, unsuitable combination of drugs, incompatibility and repeated administration. Conclusion: Through the review and comment on the special medical advice of neuronutritive auxiliary drugs, the level of rational use of neuronutritive drugs were standardized, and the rationality and safety of the use of neuronutritive drugs were ensured in patients.

Key words

comment on the prescription / neuronutritional auxiliary medication / reasons for unreasonable drug use

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
QIAO Chen, MIAO Xu, WU Lin, CHEN Xia. Analysis on Reasons of Unreasonable Medical Orders in 33 Cases of Neuronutritional Auxiliary Medication*1. KANGGANRAN YAOXUE. 2019, 16(8): 1324-1327 https://doi.org/10.13493/j.issn.1672-7878.2019.08-008

References

[1] 中国医师协会神经修复学分会儿童神经修复学专业委员会. 婴幼儿脑损伤神经修复治疗专家共识[J]. 中国当代儿科杂志,2018,20(10):785-792.
[2] Patrick M, Robert C, Nancy Carney, et al. Guidelines for the management of petiatric severe traumatic brain injury, third edition: update of the brain trauma foundation guidelines,executive summary[J]. Neurosurgery, 2019,100-113.
[3] Goodfellow JA, Willison HJ.Gangliosides and autoimmune peripheral nerve diseases[J]. Prog Mol Biol Transl Sci, 2018, 156:355-382.
[4] Opeolu Ae, Karin D. Ecommendations for the establishment of stroke systems of care: A2019 Update[J]. Stroke,2019, 50(7):e187-e210.
[5] 中国老年保健医学研究会老龄健康服务与标准化分会. 中国高龄脑卒中患者康复治疗技术专家共识[J]. 中国老年保健医学,2019,17(1):3-15.
[6] 诸美云,赵英英,丛小军. 辅助用药的规范化管理[J]. 解放军医院管理杂志,2018,25(12).DOI:10.16770/J.cnki.1008-9985.2018.12.007.
PDF(1801 KB)

72

Accesses

0

Citation

Detail
Sections
Recommended

/

〈 〉